Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-05

FDA Approved: THIOTHIXENE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' original application for thiothixene, a thioxanthene antipsychotic, for the treatment of schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thiothixene (Thiothixene)

Snippet

ORIG AP for THIOTHIXENE (THIOTHIXENE)